Invesco Ltd. Beam Therapeutics Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Invesco Ltd. holds 63,564 shares of BEAM stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,564

Previous 64,692 1.74%

Holding current value

$1.8 Million

Previous $1.52 Million 2.77%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$22.57 - $33.14 $25,458 - $37,381	-1,128 Reduced 1.74%	63,564 $1.56 Million
Q2 2024 Aug 13, 2024	SELL	$21.22 - $32.66 $14,365 - $22,110	-677 Reduced 1.04%	64,692 $1.52 Million
Q1 2024 May 14, 2024	BUY	$23.46 - $45.07 $403,699 - $775,564	17,208 Added 35.73%	65,369 $2.16 Million
Q4 2023 Feb 12, 2024	SELL	$17.69 - $30.76 $33,080 - $57,521	-1,870 Reduced 3.74%	48,161 $1.31 Million
Q3 2023 Nov 13, 2023	SELL	$23.01 - $32.46 $7,915 - $11,166	-344 Reduced 0.68%	50,031 $1.2 Million
Q2 2023 Aug 11, 2023	SELL	$29.32 - $35.99 $8,268 - $10,149	-282 Reduced 0.56%	50,375 $1.61 Million
Q1 2023 May 12, 2023	BUY	$30.15 - $48.79 $533,232 - $862,899	17,686 Added 53.64%	50,657 $1.55 Million
Q4 2022 Feb 13, 2023	BUY	$36.73 - $51.6 $154,963 - $217,700	4,219 Added 14.67%	32,971 $1.29 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $136,917 - $241,936	3,441 Added 13.59%	28,752 $1.37 Million
Q2 2022 Aug 15, 2022	BUY	$29.86 - $62.36 $89,699 - $187,329	3,004 Added 13.47%	25,311 $980,000
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $14,883 - $22,758	277 Added 1.26%	22,307 $1.28 Million
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $88,766 - $129,273	-1,305 Reduced 5.59%	22,030 $1.76 Million
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $358,825 - $568,200	4,253 Added 22.29%	23,335 $2.03 Million
Q2 2021 Aug 17, 2021	BUY	$64.12 - $128.71 $568,359 - $1.14 Million	8,864 Added 86.75%	19,082 $2.46 Million
Q1 2021 May 17, 2021	SELL	$71.28 - $120.75 $12.3 Million - $20.8 Million	-172,402 Reduced 94.4%	10,218 $818,000
Q4 2020 Feb 16, 2021	BUY	$22.24 - $95.63 $4.06 Million - $17.5 Million	182,620 New	182,620 $14.9 Million

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.99B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account